Search research articles
Contact Us
Filters
Showing results (111-120 of 165) with videos related to
Page
of 17
Sort By:
British Journal of Haematology
|
November 28, 2008
Elevated FOSB-expression; a potential marker of valproate sensitivity in AML
Farhat L Khanim, Charlotte A Bradbury, Julie Arrazi, et al.
The Oncologist
|
February 13, 2016
Association of Macroeconomic Factors With Nonrelapse Mortality After Allogeneic Hematopoietic Cell Transplantation for Adults With Acute Lymphoblastic Leukemia: An Analysis From the Acute Leukemia Working Party of the EBMT
Sebastian Giebel, Myriam Labopin, Adalberto Ibatici, et al.
The Lancet. Oncology
|
October 30, 2025
Measurable residual disease-guided interventions in patients with acute myeloid leukaemia undergoing allogeneic haematopoietic cell transplantation: best practice recommendations from the European Society for Blood and Marrow Transplantation Practice Harmonisation and Guidelines Committee
Jaime Sanz, Gesine Bug, Fabio Ciceri, et al.
Haematologica
|
August 24, 2019
Allogeneic stem cell transplantation in second complete remission for core binding factor acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Kazimierz Halaburda, Myriam Labopin, Audrey Mailhol, et al.
Bone Marrow Transplantation
|
June 29, 2023
Allogeneic hematopoietic cell transplantation for patients with AML aged 70 years or older in first remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
Enrico Maffini, Maud Ngoya, Jacques-Emmanuel Galimard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2015
Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining Study
Roni Shouval, Myriam Labopin, Ori Bondi, et al.
American Journal of Hematology
|
December 27, 2019
The impact of concomitant cytogenetic abnormalities on acute myeloid leukemia with monosomy 7 or deletion 7q after HLA-matched allogeneic stem cell transplantation
Xavier Poiré, Myriam Labopin, Emmanuelle Polge, et al.
Bone Marrow Transplantation
|
December 16, 2020
Hematopoietic stem cell transplantation for adults with relapsed acute promyelocytic leukemia in second complete remission
Jaime Sanz, Myriam Labopin, Miguel A Sanz, et al.
Bone Marrow Transplantation
|
September 16, 2022
Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMT
Arnon Nagler, Maud Ngoya, Jacques-Emmanuel Galimard, et al.
Haematologica
|
March 13, 2016
Expanding transplant options to patients over 50 years. Improved outcome after reduced intensity conditioning mismatched-unrelated donor transplantation for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the EBMT
Bipin N Savani, Myriam Labopin, Nicolaus Kröger, et al.
Page
of 17
Search research articles
Search
Showing results (111-120 of 165) with videos related to
Sort By:
Page
of 17
British Journal of Haematology
|
November 28, 2008
Elevated FOSB-expression; a potential marker of valproate sensitivity in AML
Farhat L Khanim, Charlotte A Bradbury, Julie Arrazi, et al.
The Oncologist
|
February 13, 2016
Association of Macroeconomic Factors With Nonrelapse Mortality After Allogeneic Hematopoietic Cell Transplantation for Adults With Acute Lymphoblastic Leukemia: An Analysis From the Acute Leukemia Working Party of the EBMT
Sebastian Giebel, Myriam Labopin, Adalberto Ibatici, et al.
The Lancet. Oncology
|
October 30, 2025
Measurable residual disease-guided interventions in patients with acute myeloid leukaemia undergoing allogeneic haematopoietic cell transplantation: best practice recommendations from the European Society for Blood and Marrow Transplantation Practice Harmonisation and Guidelines Committee
Jaime Sanz, Gesine Bug, Fabio Ciceri, et al.
Haematologica
|
August 24, 2019
Allogeneic stem cell transplantation in second complete remission for core binding factor acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Kazimierz Halaburda, Myriam Labopin, Audrey Mailhol, et al.
Bone Marrow Transplantation
|
June 29, 2023
Allogeneic hematopoietic cell transplantation for patients with AML aged 70 years or older in first remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
Enrico Maffini, Maud Ngoya, Jacques-Emmanuel Galimard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2015
Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining Study
Roni Shouval, Myriam Labopin, Ori Bondi, et al.
American Journal of Hematology
|
December 27, 2019
The impact of concomitant cytogenetic abnormalities on acute myeloid leukemia with monosomy 7 or deletion 7q after HLA-matched allogeneic stem cell transplantation
Xavier Poiré, Myriam Labopin, Emmanuelle Polge, et al.
Bone Marrow Transplantation
|
December 16, 2020
Hematopoietic stem cell transplantation for adults with relapsed acute promyelocytic leukemia in second complete remission
Jaime Sanz, Myriam Labopin, Miguel A Sanz, et al.
Bone Marrow Transplantation
|
September 16, 2022
Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMT
Arnon Nagler, Maud Ngoya, Jacques-Emmanuel Galimard, et al.
Haematologica
|
March 13, 2016
Expanding transplant options to patients over 50 years. Improved outcome after reduced intensity conditioning mismatched-unrelated donor transplantation for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the EBMT
Bipin N Savani, Myriam Labopin, Nicolaus Kröger, et al.
Page
of 17